Feasibility of pooling sera for HIV-1 viral RNA to diagnose acute primary HIV-1 infection and estimate HIV incidence

AIDS

Volumn 14, Issue 17, 2000, Pages 2751-2757

  Quinn, Thomas C ^a,b,e   Brookmeyer, Ron ^c   Kline, Richard ^a,b   Shepherd, Mary ^c   Paranjape, Ramesh ^d   Mehendale, Sanjay ^d   Gadkari, Deepak A ^d   Bollinger, Robert ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NATIONAL AIDS RESEARCH INSTITUTE   (India)

^e JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

HIV incidence; p24 antigen assay; Reverse transcriptase polymerase chain reaction; Serumsample pooling

Indexed keywords

ANTIGEN P24; VIRUS RNA;

ARTICLE; CALCULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INCIDENCE; INDIA; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS; SEROEPIDEMIOLOGY; VIRUS DETECTION;

FOLLOW-UP STUDIES; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; IMMUNE SERA; INCIDENCE; INDIA; POPULATION SURVEILLANCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; VIREMIA;

EID: 0034491461     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200012010-00015     Document Type: Article

References (30)

1. The detection of defective members of large populations
2. Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera
3. Successful use of pooled sera to determine HIV-1 seroprevalence in Zaire with development of cost-efficiency models
4. Reducing the cost of HIV antibody testing
5. Unlinked anonymous HIV screening of pregnant women in a low-prevalence population
6. Combining pooling and alternative algorithms in seroprevalence studies
7. Use of pooling and outpatient laboratory specimens in an anonymous seroprevalence survey of HIV infection in British Columbia, Canada
8. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development
9. Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: Preliminary results
10. Pooling of urine samples for screening for Neisseria gonorrhoeae by ligase chain reaction: Accuracy and application
11. Pooling urine samples for ligase chain reaction screening for genital Chlamydia trachomatis infection in asymptomatic women
12. Screening blood donations for viral genomes: Multicenter study of real-time simulation using pooled samples on the model of hepatitis C virus RNA detection
13. Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2
14. Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting
15. The use of polymerase chain reaction in plasma pools for the concomitant detection of hepatitis C virus and HIV type 1 RNA
16. A prospective study of a serum-pooling strategy in screening blood donors for antibody to hepatitis C virus
17. Screening for the presence of a disease by pooling sera
18. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests
19. The AIDS epidemic in India: A new method of estimating current HIV incidence rates
20. Accounting for follow-up bias in estimation of human immunodeficiency virus incidence rates
21. Direct and indirect estimates of HIV-1 incidence in a high prevalence population
22. Measuring HIV-1 incidence in northern Thailand: Prospective cohort results and estimates based on early diagnostic tests
23. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: Implications for screening of blood and tissue donors
24. The analysis of multistage pooling studies of biological specimens for estimating disease incidence and prevalence
25. Viral dynamics of HIV: Implications for drug development and therapeutic strategies
26. Biological and virologic characteristics of primary HIV infection
27. Acute primary HIV infection
28. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes
29. Risk factors and clinical presentation of acute primary HIV infection in India
30. Redefining the HIV-infectious window period in the chimpanzee model: Evidence to suggest that viral nucleic acid testing can prevent blood-borne transmission